Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

Webinar: Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

The webinar will highlight the practical tips and guide you through the crucial steps of marketing authorization upgrade to the Eurasian Economic Union (EAEU) one, ultimately leading you towards a successful submission strategy development.

As of now, all national medicinal product marketing authorizations are valid in EAEU until their expiry date. However, the mentioned marketing authorizations must be revalidated according to the EAEU regulations until December 31st, 2025.

You will learn:

What do you need to prepare and implement now to timely and successfully transition to the EAEU marketing authorization?

  1. What are the main points you need to consider when going into the upgrade procedure?
  2. What do you need to know about EAEU GMP certification?
  3. What are the readability user testing requirements?
  4. Timelines

Preparing for a marketing authorization upgrade?

Create a successful submission strategy development. Explore your options in an informal chat.

Who Should Attend?

Professionals from the following fields:

  • Regulatory Managers
  • Regulatory Strategy Managers
  • RA Partnerships Operations Manager
  • QA Managers supporting RA
  • RA Healthcare Compliance Managers

Duration: 45 min.

Speaker: Regulatory Affairs Project Manager CIS, Nargiz Asgarova, who will share her expertise regarding drug registration in the Eurasian Economic Union.

Nargiz Asgarova

Nargiz Asgarova

Regulatory Affairs Project Manager CIS

Other content that might interest you:

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information